XCUR
Exicure, Inc.
There isn't enough reported data to score XCUR yet.
XCUR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Strong |
XCUR's balance sheet is currently strong, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.
XCUR PE Valuation
XCUR has no meaningful PE right now: it lost money over the past year.
XCUR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect XCUR's losses to grow, with revenue growing.
XCUR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.34 | +$2.48 |
| Q1 2026 | -$1.57 | +$2.19 |
| Q4 2025 | -$0.79 | +$3.96 |
| Q3 2025 | -$3.64 | -$1.62 |
| Q2 2025 | -$3.82 | +$0.68 |
| Q1 2025 | -$3.76 | +$3.79 |
| Q4 2024 | -$4.75 | +$5.80 |
| Q3 2024 | -$2.02 | -118% |
XCUR is still losing money, but far less than before: $1.34 per share over the past year, against $82.50 at its worst in mid-2021.
XCUR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $21.8M | +928% |
| Q2 2022 | $2.5M | +3028% |
| Q1 2022 | $2.6M | +157% |
| Q4 2021 | $2.1M | +1413% |
| Q2 2021 | $79K | -98% |
| Q1 2021 | $997K | -89% |
| Q4 2020 | $140K | -55% |
| Q3 2020 | $2.4M | +364% |
XCUR's revenue is shrinking: $0 last quarter.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2024 | -167% | N/A |
| Q4 2022 | 85% | +720 points |
| Q3 2022 | -258% | N/A |
| Q2 2022 | -303% | +17244 points |
| Q1 2022 | -302% | +918 points |
| Q4 2021 | -635% | +8265 points |
| Q2 2021 | -17547% | -17456 points |
| Q1 2021 | -1219% | -1225 points |
XCUR's operating margin was −167% last quarter, up 134 points from the same quarter a year ago.
XCUR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.1M | +$456K |
| Q4 2025 | -$934K | -$89K |
| Q3 2025 | -$3.4M | -$3M |
| Q1 2025 | -$1.6M | -$1.1M |
| Q4 2024 | -$845K | -$29K |
| Q3 2024 | -$449K | +$963K |
| Q2 2024 | -$1.2M | +$3.6M |
| Q1 2024 | -$450K | +$2.9M |
XCUR has burned cash in almost every quarter: −$7M over the past year, against −$3M the year before.
XCUR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +25 shares |
| 1 year | +0.9% | +56.2K shares |
| 3 years | +278% | +4.7M shares |
| 5 years | +996% | +5.8M shares |
| Available history | +1379% | +5.9M shares |
XCUR has 6M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2021 | $9,000 |
XCUR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2023 | -0.2x | Net Cash |
| Q2 2023 | -0.6x | Net Cash |
| Q1 2023 | -4.0x | Net Cash |
XCUR has more cash than debt.
XCUR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.4 | Neutral |
| Stochastic | 20.3 | Neutral |
XCUR's weekly RSI is 31 (neutral) and its Stochastic is 20 (neutral).
XCUR PE vs Healthcare Sector
| Metric | XCUR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
XCUR has no meaningful PE right now: it lost money over the past year.
XCUR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 1.9% below |
| 20 week MA | $1.31 | 19% below |
| 50 week MA | $3.02 | 65% below |
| 100 week MA | $5.82 | 82% below |
| 200 week MA | $5.12 | 79% below |
XCUR is in a downtrend: it's below all five of its weekly moving averages, and 79% below its 200-week average.
XCUR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $417.0 | $289.5 | -31% |
| 2021 | $289.5 | $32.6 | -89% |
| 2022 | $32.6 | $6.40 | -80% |
| 2023 | $6.40 | $2.90 | -55% |
| 2024 | $2.90 | $17.6 | +506% |
| 2025 | $17.6 | $5.99 | -66% |
| 2026 YTD | $5.99 | $1.06 | -82% |
XCUR's yearly returns have swung widely, from +506% in 2024 to −89% in 2021. It's down 82% so far in 2026.